These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 34382337)
1. Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses. Grazia Martina M; Vicenti I; Bauer L; Crespan E; Rango E; Boccuto A; Olivieri N; Incerti M; Zwaagstra M; Allodi M; Bertoni S; Dreassi E; Zazzi M; van Kuppeveld FJM; Maga G; Radi M ChemMedChem; 2021 Dec; 16(23):3548-3552. PubMed ID: 34382337 [TBL] [Abstract][Full Text] [Related]
2. Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo. Spickler C; Lippens J; Laberge MK; Desmeules S; Bellavance É; Garneau M; Guo T; Hucke O; Leyssen P; Neyts J; Vaillancourt FH; Décor A; O'Meara J; Franti M; Gauthier A Antimicrob Agents Chemother; 2013 Jul; 57(7):3358-68. PubMed ID: 23650168 [TBL] [Abstract][Full Text] [Related]
3. Coxsackievirus mutants that can bypass host factor PI4KIIIβ and the need for high levels of PI4P lipids for replication. van der Schaar HM; van der Linden L; Lanke KH; Strating JR; Pürstinger G; de Vries E; de Haan CA; Neyts J; van Kuppeveld FJ Cell Res; 2012 Nov; 22(11):1576-92. PubMed ID: 22945356 [TBL] [Abstract][Full Text] [Related]
4. Nodosome Inhibition as a Novel Broad-Spectrum Antiviral Strategy against Arboviruses, Enteroviruses, and SARS-CoV-2. Limonta D; Dyna-Dagman L; Branton W; Mancinelli V; Makio T; Wozniak RW; Power C; Hobman TC Antimicrob Agents Chemother; 2021 Jul; 65(8):e0049121. PubMed ID: 34001511 [TBL] [Abstract][Full Text] [Related]
5. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2. Xiong R; Zhang L; Li S; Sun Y; Ding M; Wang Y; Zhao Y; Wu Y; Shang W; Jiang X; Shan J; Shen Z; Tong Y; Xu L; Chen Y; Liu Y; Zou G; Lavillete D; Zhao Z; Wang R; Zhu L; Xiao G; Lan K; Li H; Xu K Protein Cell; 2020 Oct; 11(10):723-739. PubMed ID: 32754890 [TBL] [Abstract][Full Text] [Related]
6. Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening. Pattnaik A; Palermo N; Sahoo BR; Yuan Z; Hu D; Annamalai AS; Vu HLX; Correas I; Prathipati PK; Destache CJ; Li Q; Osorio FA; Pattnaik AK; Xiang SH Antiviral Res; 2018 Mar; 151():78-86. PubMed ID: 29274845 [TBL] [Abstract][Full Text] [Related]
7. DEAD-Box Helicase DDX3X as a Host Target against Emerging Viruses: New Insights for Medicinal Chemical Approaches. Brai A; Trivisani CI; Poggialini F; Pasqualini C; Vagaggini C; Dreassi E J Med Chem; 2022 Aug; 65(15):10195-10216. PubMed ID: 35899912 [TBL] [Abstract][Full Text] [Related]
8. Viruses harness YxxØ motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target. Yuan S; Chu H; Huang J; Zhao X; Ye ZW; Lai PM; Wen L; Cai JP; Mo Y; Cao J; Liang R; Poon VK; Sze KH; Zhou J; To KK; Chen Z; Chen H; Jin DY; Chan JF; Yuen KY Sci Adv; 2020 Aug; 6(35):eaba7910. PubMed ID: 32923629 [TBL] [Abstract][Full Text] [Related]